Funded Tech Companies
GluBio Therapeutics
Wondering who backed GluBio Therapeutics? Lilly Asia Ventures, Qiming Ventures and Kaitai Capital joined the equity holders in this medical devices company.
Company Overview
Company Name
GluBio Therapeutics
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
Room 810 8th Floor Hemao Building No. 1116 Xingsha South Xin
Hangzhou Zhejiang, Undisclosed
China
Hangzhou Zhejiang, Undisclosed
China
Phone
Undisclosed
Website
Email Address
Not Recorded
Company Background Information
Overview
GluBio Therapeutics focuses on molecular glue-targeted protein degradation and provides a multi-dimensional protein degradation screening platform, an innovative target validation platform, a molecular glue rational design platform, and a proprietary library of highly active molecules.
Last Transaction
8/1/2022
Financing History
Date
Type
Amount
Management Team
Company Investors
- Lilly Asia Ventures
- Qiming Ventures
- Kaitai Capital
Browse more funded tech companies:
Share this article
About Our VC Deals Database
Our data comes from VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs